Herman van Dekken

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot et al. · New England Journal of Medicine · 2012 · 5.3K citations · Full text

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.5K citations

Surgical Oncology, Neoadjuvant Chemoradiotherapy, Esophageal Cancer +9

Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus

Jan B.F. Hulscher, Johanna W. van Sandick, Angela G. E. M. de Boer et al. · New England Journal of Medicine · 2002 · 1.6K citations · Full text

Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus

Jikke M.T. Omloo, Sjoerd M. Lagarde, Jan B.F. Hulscher et al. · Annals of Surgery · 2007 · 705 citations

POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

Leendert H. J. Looijenga, Hans Stoop, Hubert P. J. C. de Leeuw et al. · PubMed · 2003 · 646 citations

Embryology, Developmental Biology, Germ Cell +15